Concepts (307)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 19 | 2020 | 327 | 3.370 |
Why?
|
| Actins | 5 | 2020 | 341 | 2.110 |
Why?
|
| Phosphatidylserines | 11 | 2020 | 47 | 1.920 |
Why?
|
| Antiphospholipid Syndrome | 5 | 2024 | 26 | 1.710 |
Why?
|
| Phagocytosis | 8 | 2024 | 171 | 1.570 |
Why?
|
| Antigens, Surface | 7 | 2017 | 119 | 1.340 |
Why?
|
| beta 2-Glycoprotein I | 5 | 2024 | 11 | 1.170 |
Why?
|
| Platelet Activation | 8 | 2016 | 71 | 1.140 |
Why?
|
| Cardiolipins | 4 | 2024 | 18 | 1.120 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 273 | 0.990 |
Why?
|
| Platelet Aggregation | 8 | 2019 | 120 | 0.970 |
Why?
|
| Cell-Derived Microparticles | 6 | 2019 | 30 | 0.970 |
Why?
|
| Thrombosis | 10 | 2023 | 519 | 0.960 |
Why?
|
| Cofilin 1 | 3 | 2020 | 14 | 0.950 |
Why?
|
| Antibodies, Antiphospholipid | 4 | 2024 | 19 | 0.940 |
Why?
|
| Platelet Adhesiveness | 3 | 2018 | 40 | 0.930 |
Why?
|
| Endothelium, Vascular | 5 | 2012 | 520 | 0.900 |
Why?
|
| Milk Proteins | 7 | 2017 | 92 | 0.900 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2023 | 28 | 0.850 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2023 | 145 | 0.740 |
Why?
|
| Sulfoglycosphingolipids | 5 | 2011 | 8 | 0.730 |
Why?
|
| Erythrocytes | 6 | 2023 | 212 | 0.720 |
Why?
|
| Blood Coagulation | 6 | 2016 | 123 | 0.680 |
Why?
|
| Clot Retraction | 1 | 2018 | 6 | 0.620 |
Why?
|
| Focal Adhesions | 1 | 2018 | 13 | 0.610 |
Why?
|
| Macrophages | 3 | 2024 | 620 | 0.610 |
Why?
|
| Thrombocytopenia | 2 | 2013 | 221 | 0.600 |
Why?
|
| Immunoglobulin Variable Region | 3 | 2008 | 52 | 0.580 |
Why?
|
| rho-Associated Kinases | 2 | 2017 | 53 | 0.560 |
Why?
|
| Dasatinib | 1 | 2017 | 40 | 0.550 |
Why?
|
| Endothelial Cells | 2 | 2018 | 521 | 0.540 |
Why?
|
| Blood Coagulation Disorders | 4 | 2019 | 103 | 0.530 |
Why?
|
| Mice | 23 | 2024 | 17639 | 0.520 |
Why?
|
| Neutrophils | 2 | 2010 | 381 | 0.510 |
Why?
|
| Thrombin | 4 | 2013 | 59 | 0.510 |
Why?
|
| Prothrombin | 2 | 2007 | 25 | 0.500 |
Why?
|
| Granuloma, Giant Cell | 1 | 2015 | 13 | 0.500 |
Why?
|
| Autoantibodies | 5 | 2023 | 434 | 0.480 |
Why?
|
| Bone Marrow Diseases | 1 | 2015 | 41 | 0.480 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2015 | 84 | 0.470 |
Why?
|
| Blood Preservation | 2 | 2020 | 29 | 0.470 |
Why?
|
| Annexin A5 | 4 | 2016 | 15 | 0.460 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 206 | 0.440 |
Why?
|
| Platelet Factor 4 | 1 | 2013 | 22 | 0.430 |
Why?
|
| Animals | 26 | 2024 | 34081 | 0.420 |
Why?
|
| Platelet Transfusion | 1 | 2013 | 53 | 0.420 |
Why?
|
| Erythrocytes, Abnormal | 3 | 2011 | 18 | 0.410 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2004 | 191 | 0.410 |
Why?
|
| Cytoplasmic Vesicles | 2 | 2010 | 9 | 0.410 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2013 | 87 | 0.400 |
Why?
|
| Gout | 1 | 2015 | 148 | 0.400 |
Why?
|
| Collagen | 1 | 2013 | 315 | 0.400 |
Why?
|
| Hemostasis | 3 | 2008 | 69 | 0.390 |
Why?
|
| Antibodies | 1 | 2013 | 373 | 0.380 |
Why?
|
| Mice, Knockout | 10 | 2022 | 3732 | 0.380 |
Why?
|
| Heparin | 1 | 2013 | 227 | 0.380 |
Why?
|
| Macrophage Activation | 2 | 2008 | 64 | 0.380 |
Why?
|
| Thrombocythemia, Essential | 2 | 2023 | 29 | 0.370 |
Why?
|
| Polycythemia Vera | 2 | 2023 | 38 | 0.370 |
Why?
|
| Peptide Fragments | 3 | 2015 | 779 | 0.360 |
Why?
|
| Erythrocyte Inclusions | 1 | 2010 | 2 | 0.350 |
Why?
|
| Ganciclovir | 1 | 2010 | 103 | 0.340 |
Why?
|
| Cellular Senescence | 1 | 2010 | 161 | 0.320 |
Why?
|
| Bacteremia | 1 | 2013 | 407 | 0.320 |
Why?
|
| Humans | 42 | 2024 | 124602 | 0.310 |
Why?
|
| Anemia, Sickle Cell | 3 | 2011 | 338 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 10 | 2019 | 4409 | 0.300 |
Why?
|
| Signal Transduction | 3 | 2023 | 4503 | 0.300 |
Why?
|
| Leukocytes | 2 | 2006 | 205 | 0.280 |
Why?
|
| Fluorescein-5-isothiocyanate | 3 | 2017 | 29 | 0.280 |
Why?
|
| Peptide Library | 2 | 2004 | 57 | 0.280 |
Why?
|
| Citrobacter freundii | 1 | 2006 | 3 | 0.270 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1022 | 0.270 |
Why?
|
| Cell Membrane | 2 | 2008 | 461 | 0.270 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2006 | 54 | 0.260 |
Why?
|
| Apoptosis | 6 | 2020 | 1789 | 0.260 |
Why?
|
| Blood Coagulation Factors | 1 | 2006 | 35 | 0.250 |
Why?
|
| von Willebrand Factor | 2 | 2018 | 196 | 0.240 |
Why?
|
| Antiviral Agents | 1 | 2010 | 748 | 0.240 |
Why?
|
| Inclusion Bodies | 1 | 2005 | 48 | 0.230 |
Why?
|
| Antibody Specificity | 2 | 2004 | 202 | 0.230 |
Why?
|
| Plasma Cells | 1 | 2005 | 55 | 0.230 |
Why?
|
| Kringles | 1 | 2004 | 3 | 0.230 |
Why?
|
| Heart Transplantation | 2 | 2010 | 855 | 0.220 |
Why?
|
| Coombs Test | 1 | 2023 | 6 | 0.220 |
Why?
|
| Glycoproteins | 2 | 2003 | 368 | 0.220 |
Why?
|
| Mitochondria | 5 | 2019 | 682 | 0.210 |
Why?
|
| Hemolysis | 1 | 2023 | 112 | 0.210 |
Why?
|
| Protein Binding | 6 | 2015 | 1738 | 0.210 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 169 | 0.200 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 208 | 0.200 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2016 | 61 | 0.200 |
Why?
|
| Sepsis | 1 | 2006 | 478 | 0.200 |
Why?
|
| Membrane Proteins | 2 | 2008 | 1533 | 0.200 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 9 | 0.190 |
Why?
|
| Phospholipids | 1 | 2002 | 105 | 0.190 |
Why?
|
| Homocystinuria | 1 | 2022 | 23 | 0.190 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2017 | 380 | 0.190 |
Why?
|
| Nitrophenols | 2 | 2020 | 15 | 0.190 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 41 | 0.190 |
Why?
|
| Oxidoreductases | 1 | 2022 | 92 | 0.190 |
Why?
|
| Biphenyl Compounds | 2 | 2020 | 56 | 0.180 |
Why?
|
| Altitude | 1 | 2021 | 23 | 0.180 |
Why?
|
| Ribosomes | 1 | 2022 | 137 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2015 | 3040 | 0.180 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 100 | 0.180 |
Why?
|
| Brain Injuries | 2 | 2018 | 765 | 0.180 |
Why?
|
| Erythropoietin | 1 | 2021 | 104 | 0.180 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 777 | 0.170 |
Why?
|
| Fibrinolytic Agents | 1 | 2002 | 203 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1689 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2013 | 822 | 0.170 |
Why?
|
| Piperazines | 2 | 2020 | 236 | 0.160 |
Why?
|
| Flow Cytometry | 4 | 2010 | 797 | 0.160 |
Why?
|
| Aryldialkylphosphatase | 1 | 2019 | 9 | 0.160 |
Why?
|
| Boron Compounds | 2 | 2010 | 32 | 0.160 |
Why?
|
| Sulfonamides | 2 | 2020 | 261 | 0.160 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 811 | 0.160 |
Why?
|
| Bone Marrow | 2 | 2015 | 324 | 0.160 |
Why?
|
| Cytoskeleton | 1 | 2020 | 178 | 0.160 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 78 | 0.150 |
Why?
|
| Cell Line | 4 | 2015 | 2750 | 0.150 |
Why?
|
| Cell Adhesion | 3 | 2011 | 324 | 0.150 |
Why?
|
| Microvessels | 1 | 2018 | 56 | 0.150 |
Why?
|
| Gene Deletion | 2 | 2018 | 791 | 0.140 |
Why?
|
| Male | 14 | 2022 | 61198 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2019 | 264 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 43 | 0.140 |
Why?
|
| Repressor Proteins | 1 | 2022 | 816 | 0.140 |
Why?
|
| Hypercholesterolemia | 1 | 2019 | 228 | 0.140 |
Why?
|
| Capillary Permeability | 1 | 2017 | 75 | 0.140 |
Why?
|
| Talin | 1 | 2016 | 8 | 0.140 |
Why?
|
| Permeability | 1 | 2017 | 122 | 0.130 |
Why?
|
| Gene Expression | 2 | 2023 | 1562 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 485 | 0.130 |
Why?
|
| Platelet Function Tests | 3 | 2019 | 40 | 0.130 |
Why?
|
| Mitochondrial Membranes | 1 | 2016 | 30 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 457 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 159 | 0.130 |
Why?
|
| Catalase | 1 | 2015 | 50 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 292 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 96 | 0.120 |
Why?
|
| Uric Acid | 1 | 2015 | 94 | 0.120 |
Why?
|
| P-Selectin | 2 | 2005 | 78 | 0.120 |
Why?
|
| Phosphorylation | 2 | 2017 | 1615 | 0.110 |
Why?
|
| Endotoxemia | 1 | 2015 | 58 | 0.110 |
Why?
|
| Immunoglobulin Fragments | 2 | 2004 | 12 | 0.110 |
Why?
|
| Lim Kinases | 1 | 2013 | 9 | 0.110 |
Why?
|
| Hypoxia | 1 | 2015 | 247 | 0.110 |
Why?
|
| Amides | 1 | 2013 | 89 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 4352 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2013 | 192 | 0.100 |
Why?
|
| Specimen Handling | 1 | 2013 | 142 | 0.100 |
Why?
|
| Liposomes | 2 | 2003 | 174 | 0.100 |
Why?
|
| Epitopes | 2 | 2004 | 432 | 0.100 |
Why?
|
| Pyridines | 1 | 2013 | 229 | 0.100 |
Why?
|
| Binding Sites | 2 | 2007 | 1295 | 0.100 |
Why?
|
| Protein Subunits | 2 | 2022 | 164 | 0.090 |
Why?
|
| Biopsy | 1 | 2015 | 1237 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2019 | 914 | 0.090 |
Why?
|
| Endocytosis | 1 | 2012 | 125 | 0.090 |
Why?
|
| Erythrocyte Membrane | 1 | 2011 | 23 | 0.090 |
Why?
|
| Cyclophilins | 1 | 2010 | 19 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 221 | 0.090 |
Why?
|
| Cytochromes c | 1 | 2010 | 51 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 260 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 325 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 337 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 356 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 486 | 0.080 |
Why?
|
| Receptors, Androgen | 1 | 2012 | 413 | 0.080 |
Why?
|
| Phenanthrenes | 1 | 2008 | 5 | 0.080 |
Why?
|
| Maleimides | 1 | 2008 | 11 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 261 | 0.080 |
Why?
|
| Cytomegalovirus | 1 | 2010 | 270 | 0.080 |
Why?
|
| Ethylmaleimide | 1 | 2008 | 13 | 0.080 |
Why?
|
| Calcimycin | 1 | 2008 | 26 | 0.080 |
Why?
|
| Edetic Acid | 1 | 2008 | 24 | 0.080 |
Why?
|
| Calcium Chloride | 1 | 2008 | 22 | 0.080 |
Why?
|
| Cattle | 2 | 2007 | 565 | 0.080 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2008 | 8 | 0.070 |
Why?
|
| Hemorheology | 1 | 2008 | 25 | 0.070 |
Why?
|
| Erythroid Cells | 1 | 2008 | 26 | 0.070 |
Why?
|
| Cytomegalovirus Infections | 1 | 2010 | 218 | 0.070 |
Why?
|
| Erythropoiesis | 1 | 2008 | 40 | 0.070 |
Why?
|
| Spleen | 1 | 2008 | 281 | 0.070 |
Why?
|
| Aztreonam | 1 | 2006 | 4 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2007 | 185 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 229 | 0.070 |
Why?
|
| HL-60 Cells | 1 | 2006 | 31 | 0.070 |
Why?
|
| Fibrinogen | 1 | 2007 | 154 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2013 | 3281 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 647 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2008 | 258 | 0.060 |
Why?
|
| Hyalin | 1 | 2005 | 6 | 0.060 |
Why?
|
| Thromboplastin | 1 | 2005 | 17 | 0.060 |
Why?
|
| Membrane Fusion | 1 | 2005 | 37 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 2521 | 0.060 |
Why?
|
| Autophagy | 1 | 2008 | 393 | 0.060 |
Why?
|
| In Vitro Techniques | 2 | 2005 | 969 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 59 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2005 | 89 | 0.060 |
Why?
|
| Bacteriophage M13 | 1 | 2004 | 18 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2004 | 26 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2004 | 48 | 0.060 |
Why?
|
| Binding Sites, Antibody | 1 | 2004 | 99 | 0.060 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2004 | 24 | 0.060 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2003 | 4 | 0.060 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 26 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 217 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2005 | 212 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 184 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 1544 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 23 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 31 | 0.050 |
Why?
|
| Brain | 1 | 2015 | 2983 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 2705 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 98 | 0.050 |
Why?
|
| Monocytes | 1 | 2005 | 352 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 390 | 0.050 |
Why?
|
| Pregnancy | 1 | 2015 | 7182 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2023 | 108 | 0.050 |
Why?
|
| Reticulocytes | 2 | 2015 | 42 | 0.050 |
Why?
|
| Sjogren's Syndrome | 1 | 2003 | 89 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 3878 | 0.050 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 16 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 57 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 72 | 0.050 |
Why?
|
| Calcium | 1 | 2006 | 1100 | 0.050 |
Why?
|
| Anticoagulants | 2 | 2005 | 589 | 0.040 |
Why?
|
| Drug Design | 1 | 2002 | 147 | 0.040 |
Why?
|
| Time Factors | 2 | 2008 | 6292 | 0.040 |
Why?
|
| Heterozygote | 1 | 2002 | 672 | 0.040 |
Why?
|
| HIV-1 | 1 | 2004 | 465 | 0.040 |
Why?
|
| Stroke | 1 | 2008 | 984 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 453 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2020 | 250 | 0.040 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2019 | 47 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2019 | 87 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 664 | 0.040 |
Why?
|
| Mutation | 2 | 2022 | 5825 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 1431 | 0.040 |
Why?
|
| Survival | 1 | 2017 | 19 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2017 | 88 | 0.040 |
Why?
|
| Adult | 2 | 2010 | 29440 | 0.040 |
Why?
|
| Homeostasis | 1 | 2021 | 685 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2022 | 996 | 0.030 |
Why?
|
| Female | 3 | 2022 | 66491 | 0.030 |
Why?
|
| Heart-Assist Devices | 1 | 2005 | 1021 | 0.030 |
Why?
|
| Cyclooxygenase 1 | 1 | 2016 | 40 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 214 | 0.030 |
Why?
|
| Tyrosine | 2 | 2008 | 150 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2426 | 0.030 |
Why?
|
| Polycythemia | 1 | 2015 | 43 | 0.030 |
Why?
|
| Fibrin | 1 | 2015 | 64 | 0.030 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2015 | 67 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2015 | 88 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 241 | 0.030 |
Why?
|
| Disease Progression | 2 | 2012 | 2047 | 0.030 |
Why?
|
| Castration | 1 | 2012 | 33 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1690 | 0.030 |
Why?
|
| Chromones | 1 | 2012 | 22 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 409 | 0.030 |
Why?
|
| Androstadienes | 1 | 2012 | 49 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 90 | 0.020 |
Why?
|
| Morpholines | 1 | 2012 | 57 | 0.020 |
Why?
|
| HIV Infections | 1 | 2004 | 1892 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2008 | 1018 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1390 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 1005 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 406 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2011 | 27 | 0.020 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2011 | 30 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2006 | 12324 | 0.020 |
Why?
|
| Single-Chain Antibodies | 1 | 2011 | 44 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2011 | 73 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3424 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2816 | 0.020 |
Why?
|
| Middle Aged | 2 | 2005 | 26714 | 0.020 |
Why?
|
| Aged | 1 | 2006 | 19703 | 0.020 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2008 | 4 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 837 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 61 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 163 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1697 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 806 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2012 | 1497 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 3339 | 0.020 |
Why?
|
| Factor VIIa | 1 | 2005 | 24 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2004 | 22 | 0.010 |
Why?
|
| Solubility | 1 | 2005 | 135 | 0.010 |
Why?
|
| Leukocyte Common Antigens | 1 | 2005 | 90 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2004 | 58 | 0.010 |
Why?
|
| Acute Disease | 1 | 2008 | 1110 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 355 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 796 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 311 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2004 | 106 | 0.010 |
Why?
|
| Waiting Lists | 1 | 2005 | 227 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 891 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 1089 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 4256 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 325 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 537 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 2891 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 3441 | 0.010 |
Why?
|